findmyKOL

Steven Magill, MD

Basic profile

Actuant

ORCIDNPI
RegionMenomonee Falls, WI · MidwestSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Steven Magill is an Endocrinology/Metabolic physician affiliated with Actuant. OpenAlex indexes 38 publications with 1,245 citations (h-index 11).

Overview

Scholarship

indexed output and impact (OpenAlex)
38publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,245citations

Total citations across indexed works.

11h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Musculoskeletal

    82.9%
    Other drugs affecting bone structure and mineralization72.4%
    Romosozumab-aqqg100%
    Part B, office-administered16 patients
    RANK Ligand Inhibitor8.9%
    Denosumab100%
    Part B, office-administered12 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    10.1%
    Insulin Analog4.1%
    Lantus Solostar34%Humalog Kwikpen U-10014%Novolog Flexpen12%Lantus7%Tresiba Flextouch U-1006%Tresiba Flextouch U-2004%Humalog4%Toujeo Solostar4%Basaglar Kwikpen U-1004%Novolog3%Insulin Lispro Kwikpen U-1003%Toujeo Max Solostar3%Insulin Lispro2%
    Part D<11 patients
    Biguanide (metformin)2.4%
    Metformin Hcl Er85%Metformin Hcl15%
    Part D87 patients

    + 6 more classes in this area

  • Hormonal (systemic)

    5.1%
    l-Thyroxine3.7%
    Levothyroxine Sodium80%Synthroid15%Levoxyl5%
    Part D<11 patients
    Thyroid Hormone Synthesis Inhibitor0.6%
    Methimazole100%
    Part D29 patients

    + 5 more classes in this area

Where care is delivered (Part B)0.1% facility · 99.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”